Flu season has a way of turning an ordinary fall week into cancelled plans, missed shifts and crowded waiting rooms. For 2026–27, Canadian health authorities are again recommending seasonal influenza vaccination broadly, but there are several details worth knowing about timing, vaccine types, age-specific recommendations and people who should be especially careful not to miss it. The guidance also reflects newer issues, including the shift toward three-strain vaccines and concern about avian influenza exposure among certain workers and outdoor groups.
These 16 things Canadians should know about getting a flu shot in 2026 explain what has changed, what has stayed the same and why the right vaccine can look different depending on age, health and circumstances.
The Recommendation Starts at Six Months of Age

Canada’s basic recommendation remains remarkably broad: seasonal influenza vaccine should be offered every year to almost everyone aged six months and older who does not have a contraindication. That means vaccination is not reserved for seniors, people with chronic diseases or children in school. Healthy working-age adults are included as well, even when their personal risk of hospitalization may be lower than that of priority groups.
The broad recommendation reflects the size of influenza’s health burden. NACI’s 2026–27 summary notes that, before the COVID-19 pandemic, influenza was associated with roughly 15,000 hospitalizations per year in Canada between the 2010–11 and 2018–19 seasons. Individual seasons vary considerably, but flu can worsen existing illness and lead to complications including hospitalization and death. Vaccination does not eliminate every infection, yet Canadian public-health guidance continues to describe it as the most effective form of protection against influenza and its complications. For many households, that makes an annual appointment part of ordinary fall planning rather than something reserved for an emergency.
Early Fall Is Still the Main Vaccination Window

Questions about timing have become more complicated because influenza-vaccine protection can gradually decline over a season. A Canadian evidence review published in 2026 examined 49 studies and found that vaccine effectiveness was generally strongest within one to three months after vaccination and then declined progressively. That has prompted an understandable question: would waiting until later in the fall provide better protection during the winter peak?
NACI’s answer for 2026–27 is essentially no. Its review concluded that evidence does not show substantial or consistent population-level benefits from deliberately delaying vaccination. Influenza seasons themselves are unpredictable, and delaying a shot can create a period in which someone is completely unvaccinated. Early-fall vaccination is therefore still considered capable of providing useful protection through most of the season. Canada’s public-health guidance also notes that it generally takes about two weeks after vaccination for the best protection to develop. For a family trying to be protected before holiday gatherings or a workplace outbreak, that delay matters when choosing an appointment date.
Vaccine Effectiveness Changes From One Season to Another

A flu shot should not be understood as an invisible shield that makes infection impossible. Influenza vaccine effectiveness changes depending on the viruses circulating, how closely those viruses match the vaccine strains, the recipient’s age and health, and which influenza subtype dominates. That is why one season can produce stronger protection than another even though vaccination recommendations remain consistent.
Canada saw a useful example during the 2025–26 season. The Canadian Sentinel Practitioner Surveillance Network estimated at mid-season that vaccination reduced the risk of medically attended illness caused by influenza A(H3N2) by about 40% among vaccinated people compared with unvaccinated people. That figure should not be treated as a prediction for the 2026–27 vaccine; the viruses and vaccine match can change. It does show why effectiveness is better described as risk reduction than total prevention. Vaccination can still matter when protection is imperfect, particularly for people more likely to develop complications. It also explains why authorities update the vaccine formulation and review performance every year instead of assuming last winter’s results will simply repeat.
Canada Is Moving to Three-Strain Flu Vaccines

Some Canadians may notice unfamiliar wording on vaccine information this year. The Canadian Immunization Guide currently lists trivalent influenza vaccines as the principal preparations for the 2026–27 season. “Trivalent” means the vaccine targets three influenza components: an A(H1N1) virus, an A(H3N2) virus and an influenza B virus from the Victoria lineage.
The change is linked to what has happened to another influenza B lineage. B/Yamagata viruses have not been confirmed as naturally circulating seasonal viruses for several years, leading the World Health Organization and Canadian authorities to support removing that component from flu vaccines. Some quadrivalent products, which historically covered four components, may remain authorized in Canada during the transition even if they are no longer being marketed for a particular season. The move from four strains to three therefore should not be interpreted as manufacturers simply providing “less” protection. It reflects changes in the viruses actually circulating. Manufacturers supplying Canada are expected to use the influenza strains recommended for the Northern Hemisphere each season.
Not Every Flu Vaccine Is Intended for Every Age

Asking for “the flu vaccine” can make the choice sound simpler than it really is. Canada has several categories of influenza vaccine, including standard-dose inactivated products, a cell-culture-based vaccine, an adjuvanted vaccine, a high-dose vaccine and a live attenuated nasal vaccine. Product authorization and recommendations depend partly on the recipient’s age.
For example, the live attenuated nasal vaccine is an option for eligible people from age two through 59, but it is not appropriate for everyone within that age range. Infants younger than two cannot receive it, and NACI lists contraindications or recommendations against its use in people with certain conditions. Adults aged 60 and older use injectable vaccine options instead. Children as young as six months can receive appropriate injectable influenza vaccines. Even within an authorized age group, availability can differ across provinces and territories or from one season to another. The practical lesson is that a pharmacy or clinic may offer a product different from the one a person received last year without that difference meaning something is wrong.
Adults 65 and Older Have Different Vaccine Guidance

Turning 65 changes more than the birthday candles when influenza vaccination is concerned. NACI recommends that adults 65 and older preferentially receive an enhanced influenza vaccine when one is available. Current options include high-dose and adjuvanted inactivated vaccines, which are designed to produce a stronger immune response than conventional standard-dose vaccines in older adults.
That preference reflects the disproportionate burden influenza can impose with age and evidence that enhanced vaccines can improve protection. It does not mean an older adult should remain unvaccinated because the preferred product is unavailable. NACI explicitly says an age-appropriate alternative should be used when a preferred option cannot be obtained. Uptake also leaves room for improvement: Canada’s 2025–26 respiratory vaccination survey estimated influenza coverage at 64% among adults 65 and older. That was higher than for younger adults but still below Canada’s longstanding 80% coverage goal for groups at high risk of influenza complications. In practice, asking what formulation is being offered can be worthwhile, but obtaining timely vaccination remains the larger objective.
A Child’s First Flu Season May Require Two Doses

Parents bringing a young child for a first influenza vaccination can encounter a schedule adults rarely think about. Children from six months to under nine years of age who are receiving a seasonal influenza vaccine for the first time need two doses during that season. The doses should be separated by at least four weeks.
After a child in that age range has previously received one or more seasonal influenza vaccine doses, the routine recommendation becomes one dose in subsequent seasons. Children aged nine and older normally receive one dose per season, just like adults. The distinction can catch families off guard when a first appointment occurs relatively late in the fall. A child receiving dose one in November, for example, cannot simply return a few days later to complete the schedule; the minimum four-week interval still applies. That is another reason vaccination programs emphasize getting started during the fall. Families uncertain about an older child’s previous influenza-vaccine history can check immunization records or speak with the clinic administering the vaccine before assuming whether one or two doses are needed.
Babies Under Six Months Cannot Receive a Seasonal Flu Vaccine

One of the groups vulnerable to influenza is also too young to receive the seasonal vaccine directly. Influenza vaccines used in Canada are not recommended for infants younger than six months because evidence is insufficient to demonstrate effectiveness at that age and the available products are not authorized for them.
Protection therefore depends heavily on the people surrounding a newborn. NACI places household contacts of infants younger than six months among the groups for whom vaccination is particularly important. That includes families expecting a baby during flu season as well as people regularly caring for young infants. Vaccination during pregnancy can add another layer of protection because antibodies produced by the pregnant parent can cross the placenta and help protect an infant during the first months after birth. The situation changes the way the flu shot is sometimes framed: vaccination is not solely a decision about the recipient’s personal risk. In a home with a newborn, lowering the likelihood of bringing influenza into the household can have particular importance.
Pregnancy Is a Reason to Prioritize the Flu Vaccine

Pregnancy is specifically listed by NACI as a situation in which seasonal influenza vaccination is particularly important. Canadian guidance recommends a non-live influenza vaccine during every pregnancy, and it can be given at any stage of pregnancy. Influenza itself can be more consequential during pregnancy, with increased risk of influenza-related morbidity and hospitalization as well as potential adverse outcomes for the pregnancy.
Vaccination also offers a two-generation benefit. Antibodies can be transferred across the placenta, giving newborns some protection during the first months of life, when they remain too young to receive their own influenza vaccine. If a pregnancy happens to extend across two separate influenza seasons, Canadian guidance allows vaccination in each season. The important distinction involves the type of vaccine: the live attenuated nasal influenza vaccine is contraindicated during pregnancy, while non-live influenza vaccines are recommended. Canada’s immunization guidance reports a substantial body of evidence supporting the safety of non-live influenza vaccination during pregnancy. For someone balancing several prenatal appointments, the flu vaccine can therefore be incorporated into routine care rather than postponed until after delivery.
Chronic Health Conditions Can Make Vaccination More Important

NACI’s priority list covers substantially more than age. It includes people with cardiac or pulmonary disorders, diabetes and other metabolic diseases, cancer, immune-compromising conditions, renal disease, anemia or hemoglobin disorders, and several neurologic or neurodevelopmental conditions. Class 3 obesity, defined in the guidance as a body mass index of 40 kg/m² or higher, is also included.
Children and teenagers receiving long-term acetylsalicylic acid, commonly known as aspirin, are another specific priority group because influenza is associated with a risk of Reye syndrome in this setting. Cardiovascular disease deserves additional attention as well. NACI has reviewed evidence suggesting influenza vaccination may offer broader cardiovascular benefits in high-risk people, including those with pre-existing cardiovascular disease. None of this means every person with a chronic condition will experience severe influenza, but it changes the balance of risk. A mild respiratory infection for one person can destabilize asthma, diabetes or another underlying condition in someone else. That is why vaccination programs place these groups near the front of the priority list rather than treating every recipient as medically identical.
Egg Allergy Usually Does Not Prevent Flu Vaccination

The egg-allergy question has lingered for years because many influenza vaccines historically have been produced using egg-based manufacturing. Current Canadian guidance is much less restrictive than some people remember. An egg allergy, even a history of a severe reaction to egg, is not considered a contraindication to receiving an influenza vaccine.
NACI says egg-allergic individuals may receive any appropriate influenza vaccine, including egg-based products and the live attenuated vaccine when otherwise eligible. A special influenza-vaccine skin test is not required, the full recommended dose can be used, and vaccination does not have to take place in a special medical setting solely because of the egg allergy. That does not mean allergies are irrelevant. A previous anaphylactic reaction to a particular influenza vaccine or a confirmed allergy to another component of the chosen product can still be a contraindication and warrants review by a healthcare professional. The distinction matters because someone who skipped years of flu vaccination after being told as a child that egg allergy made the shot unsafe may now be working from guidance that has substantially changed.
Flu and COVID-19 Vaccines Can Be Given at the Same Visit

For people already planning a fall COVID-19 vaccination, a second appointment solely to create a gap before the flu shot is generally unnecessary. NACI states that seasonal influenza vaccines can be administered on the same day as other vaccines or at any time before or after them, including COVID-19 vaccines.
Canadian evidence reviews of concurrent vaccination have not identified safety, effectiveness or immune-response concerns that would require routine separation. This approach is particularly useful because many jurisdictions organize their fall respiratory-vaccine campaigns around the same period. Someone eligible for both may therefore leave one appointment with both vaccinations completed rather than relying on another trip weeks later. When two injectable vaccines are administered during one visit, providers generally use different injection sites. Individual circumstances can still affect which vaccines are being recommended in a particular year, especially because provincial and territorial eligibility for publicly funded COVID-19 vaccination can differ. But from the standpoint of influenza-vaccine timing, receiving another vaccine does not normally create a mandatory waiting period.
The Flu Shot Cannot Give Someone Influenza

Feeling achy after vaccination can make the old claim that the flu shot “gave someone the flu” seem convincing, particularly when symptoms appear the next morning. Canadian public-health guidance is clear, however: influenza vaccination does not cause influenza illness. Injectable inactivated vaccines do not contain live influenza virus capable of producing flu.
Mild reactions can occur because the immune system is responding to vaccination. Soreness around the injection site and short-lived systemic symptoms can happen, while nasal congestion and a runny nose are among common reactions to the live attenuated nasal vaccine. Canada’s flu guidance says vaccine side effects are generally mild and disappear on their own within a few days, while severe reactions are very rare. Timing can also create confusion. It takes roughly two weeks for vaccination to provide its best protection, so someone exposed to influenza shortly before vaccination or during that window can still become sick. Other respiratory viruses circulating in the fall can produce similar symptoms. None of those scenarios means an inactivated flu shot produced an influenza infection.
A Few Medical Situations Require Extra Screening

Although influenza vaccination is recommended very broadly, “almost everyone” is not the same as absolutely everyone. A history of anaphylaxis after a previous dose of a specific influenza vaccine, or proven immediate or anaphylactic hypersensitivity to one of that product’s components other than egg, can be a contraindication. In such situations, a healthcare professional may need to determine whether a different formulation is appropriate.
Guillain-Barré syndrome also appears in Canadian influenza-vaccine safety guidance, particularly when it occurred within six weeks of a previous influenza vaccination. Serious acute illness can be a reason to postpone vaccination until symptoms have improved, although minor illness does not automatically require a delay. The nasal live attenuated vaccine has additional restrictions. NACI lists severe asthma, recent active or medically attended wheezing, certain immune-compromising conditions and pregnancy among contraindications in relevant age groups, and it is not recommended for some people with chronic conditions. This is why a proper vaccine appointment includes screening questions even though the shot itself may take only seconds.
Where Canadians Get Vaccinated Depends on Where They Live

The federal recommendation is national, but influenza programs are delivered through provinces and territories. Vaccine supply, which formulations are offered to particular age groups and where appointments are available can consequently differ across the country. Canada.ca directs residents to provincial and territorial flu-clinic information and notes that flu clinics across Canada offer free vaccination.
For many adults, the pharmacy has become the familiar vaccination site. In the federal Seasonal Respiratory Vaccination Coverage Survey for 2025–26, 60% of vaccinated adults reported receiving their influenza vaccine at a pharmacy, compared with 14% at a doctor’s office. Overall adult coverage was estimated at 34%, with 64% coverage among people 65 and older, 36% among adults under 65 with a chronic medical condition and 21% among those under 65 without one. The same survey found that 19% of unvaccinated respondents said they simply did not get around to vaccination. Convenient access therefore matters: for many Canadians, the biggest barrier may be completing the appointment rather than deciding whether vaccination is medically appropriate.
H5N1 Has Added Another Reason for Some Canadians to Prioritize the Shot

Seasonal flu vaccination has acquired an additional public-health role as avian influenza A(H5N1) continues to affect birds and some mammals. NACI now specifically identifies people whose occupations or recreational activities increase their chance of H5N1 exposure as a group for whom seasonal influenza vaccination is particularly important.
The distinction is critical: the ordinary seasonal flu vaccine does not protect a person from becoming infected with H5N1. Instead, reducing seasonal influenza may lower the possibility of someone being infected with seasonal and avian influenza viruses at the same time. Such co-infection is undesirable because influenza viruses can exchange genetic material under certain circumstances. Groups highlighted in Canadian guidance include people working with poultry or livestock, veterinarians and veterinary staff, workers handling sick or dead animals, some laboratory personnel, and people hunting or trapping wild birds or mammals. Seasonal vaccination does not replace personal protective equipment, biosecurity measures or other H5N1 precautions. It is another layer of prevention in a group with an unusual potential exposure.
16 Costco Canada Habits That Could Be Costing Shoppers More Than They Save

The Executive Membership can feel like an obvious upgrade because the 2% annual reward sounds straightforward. For households that spend heavily at Costco Canada, the extra fee may be easy to justify. But the habit becomes costly when shoppers upgrade first and calculate later. A Gold Star Membership costs less, while Executive costs more and only pays off if eligible annual spending is high enough to offset the difference.
16 Costco Canada Habits That Could Be Costing Shoppers More Than They Save